Freezer N J, Bucens I K, Robertson C F
Department of Thoracic Medicine, Royal Children's Hospital, Parkville, Victoria, Australia.
J Paediatr Child Health. 1995 Jun;31(3):172-5. doi: 10.1111/j.1440-1754.1995.tb00779.x.
To study the postoperative outcome of infants under the age of 18 months in whom an adenotonsillectomy had been performed, with particular emphasis on the pre- and postoperative weight gain and linear growth velocities, and the resolution of symptoms of obstructive sleep apnoea (OSA).
A retrospective study of all infants in whom an adenotonsillectomy had been performed during the 5 year period to January 1990. Details of pre- and postoperative outcome variables were obtained by review of hospital and office records and by telephone calls to the parents.
Complete data were available for 29 (76%) of the 38 infants in whom an adenotonsillectomy had been performed. The data from these infants are reported. Pre-operatively, all infants had clinical symptoms of OSA, and 52% of infants also presented with failure to thrive (FTT). Seven infants were dysmorphic: three had Down syndrome, three had a craniofacial anomaly and one infant had Mobius syndrome. Following adenotonsillectomy, 23 infants (79%) had complete resolution of their OSA symptoms. Two infants with Down syndrome required a tracheostomy to relieve persistent upper airway obstruction. Eighty-seven per cent of the infants with pre-operative FTT had a significant increase in weight gain velocity postoperatively (mean 195.1 +/- 80.8 s.d. vs 509.8 +/- 249.1 g/month; P < 0.001), including the infants with mild persistent symptoms of OSA. The weight gain velocity of infants who were not failing to thrive pre-operatively did not change significantly following adenotonsillectomy (328.1 +/- 106.9 vs 333.2 +/- 146.4 g/month; P = 0.82). The linear growth velocity of all infants did not change significantly postoperatively.
OSA should be considered in infants with FTT, as adenotonsillectomy is an effective treatment for OSA in infancy, and the weight gain velocity of these infants may increase significantly postoperatively. Overnight oximetry or other physiological studies may be required if the clinical signs and symptoms of OSA are equivocal.
研究18个月以下接受腺样体扁桃体切除术的婴儿的术后转归,特别关注术前和术后的体重增加及线性生长速度,以及阻塞性睡眠呼吸暂停(OSA)症状的缓解情况。
对截至1990年1月的5年期间内所有接受腺样体扁桃体切除术的婴儿进行回顾性研究。通过查阅医院和门诊记录以及致电家长获取术前和术后结局变量的详细信息。
38例接受腺样体扁桃体切除术的婴儿中有29例(76%)获得了完整数据。报告了这些婴儿的数据。术前,所有婴儿均有OSA的临床症状,52%的婴儿还伴有生长发育迟缓(FTT)。7例婴儿存在畸形:3例患有唐氏综合征,3例有颅面畸形,1例婴儿患有莫比乌斯综合征。腺样体扁桃体切除术后,23例婴儿(79%)的OSA症状完全缓解。2例唐氏综合征婴儿需要气管切开术以缓解持续性上呼吸道梗阻。术前有FTT的婴儿中,87%术后体重增加速度显著加快(平均为195.1±80.8标准差对509.8±249.1克/月;P<0.001),包括有轻度持续性OSA症状的婴儿。术前无生长发育迟缓的婴儿在腺样体扁桃体切除术后体重增加速度无显著变化(328.1±106.9对333.2±146.4克/月;P=0.82)。所有婴儿的线性生长速度术后无显著变化。
FTT婴儿应考虑患有OSA,因为腺样体扁桃体切除术是婴儿OSA的有效治疗方法,且这些婴儿术后体重增加速度可能显著加快。如果OSA的临床体征和症状不明确,可能需要进行夜间血氧饱和度测定或其他生理研究。